Last edition
News about Global Pharma
Taiwan MOHW Approves ACRO Biomedical's ABCcolla Collagen Ophthalmic Matrix
According to WHO, over 20 million people suffer from blindness due to corneal injuries or infections, yet only around 100,000 corneal transplants are performed annually, leading to a severe shortage.
Global Pharma | 14/04/2025 | By Abha | 421
Turbett Surgical Receives FDA 510(k) Clearance for Enhanced Instrument Pod Portfolio
Turbett Surgical's Instrument Pods receive FDA 510(k) clearance, boasting increased weight capacity of up to 300 lbs for the TS1200 and expanded lumen validation for improved surgical instrument management.
Global Pharma | 11/04/2025 | By Manvi | 613
Intrinsic Therapeutics Appoints Keith Valentine as President and Chief Executive Officer
Intrinsic Therapeutics, announced the appointment of Keith Valentine as President and Chief Executive Officer. Valentine will also join the Board of Directors and will begin his role in early May.
Global Pharma | 11/04/2025 | By Manvi | 326
Akums Drugs & Pharmaceuticals Ltd. has installed a 600 kWp rooftop solar power plant at its warehouse in Haridwar, Uttarakhand marking a major step in its commitment to sustainability and clean energy adoption.
Global Pharma | 11/04/2025 | By Manvi | 716
Innoblative Wins FDA IDE Approval for SIRA Device, Advancing Breast Cancer Surgery Innovation
Innoblative's SIRA device is a single-use, disposable applicator built for intraoperative ablation of the post-lumpectomy cavity during breast conserving surgery.
Global Pharma | 11/04/2025 | By Abha | 614
Novartis Unveils USD 23 Billion US Investment to Boost Domestic Drug Manufacturing and Research
Over the next 5 years, Novartis will establish 1 biomedical research innovation hub in San Diego, CA, its second global R&D hub in the US.
Global Pharma | 11/04/2025 | By Abha | 763
Biocon Biologics Announces USFDA Approval of JOBEVNE Biosimilar for Cancer Treatment
Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd announced that the US Food and Drug Administration (USFDA) has approved Jobevne™ (bevacizumab-nwgd), a biosimilar Bevacizumab for intravenous use.
Global Pharma | 10/04/2025 | By Manvi | 518
OneSource Specialty Pharma’s flagship Unit 2 facility in Bengaluru has received GMP certification from Brazil's ANVISA, enabling it to supply high-quality biologics and drug-device combinations to the Brazilian market.
Global Pharma | 10/04/2025 | By Manvi | 413
Eko Health Launches CORE 500 Digital Stethoscope and Eko+ Membership in Canada
Eko Health announced the launch of the CORE 500™ Digital Stethoscope and Eko+ Membership in Canada. This expansion follows Health Canada approval of the CORE 500 Digital Stethoscope and Eko+, making it available to Canadian clinicians seeking advanced digital auscultation technology to support cardiac and pulmonary care.
Global Pharma | 10/04/2025 | By Manvi | 660
The collaboration aims to develop mucosal vaccines by combining Orexo's powder-based drug delivery technology AmorphOX with Abera's innovative and patented vaccine platform BERA™.
Global Pharma | 10/04/2025 | By Abha | 368
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy